It takes the average reader 2 hours and 21 minutes to read Perspectives on Biomarker and Surrogate Endpoint Evaluation by Institute of Medicine
Assuming a reading speed of 250 words per minute. Learn more
In 2010 the Institute of Medicine (IOM) recommended a framework for the evaluation of biomarkers in the chronic disease setting. Published in the book Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease, the framework is intended to bring consistency and transparency to the previously disparate process of biomarker evaluation. Following the book's release, the IOM convened a 2-day discussion forum in Washington, DC, in order to provide an opportunity for stakeholders to learn about, react to, and discuss the book. Presentations reviewed the authoring committee's work process, recommendations, and provided perspectives on the book from the point of view of participants. Thomas Fleming, professor of biostatistics and statistics at the University of Washington, gave a keynote presentation on the critical issues in the validation of surrogate endpoints, a specific use of a biomarker. The present volume recounts the discussion forum proceedings, focusing in turn on each represented sector. A summary of Dr. Fleming's presentation then sets the committee's recommendations within the context of biomarker utilization. Lastly, this summary examines the main themes raised by stakeholders, and the challenges and opportunities presented to stakeholders by the book's recommendations.
Perspectives on Biomarker and Surrogate Endpoint Evaluation by Institute of Medicine is 141 pages long, and a total of 35,391 words.
This makes it 48% the length of the average book. It also has 43% more words than the average book.
The average oral reading speed is 183 words per minute. This means it takes 3 hours and 13 minutes to read Perspectives on Biomarker and Surrogate Endpoint Evaluation aloud.
Perspectives on Biomarker and Surrogate Endpoint Evaluation is suitable for students ages 10 and up.
Note that there may be other factors that effect this rating besides length that are not factored in on this page. This may include things like complex language or sensitive topics not suitable for students of certain ages.
When deciding what to show young students always use your best judgement and consult a professional.
Perspectives on Biomarker and Surrogate Endpoint Evaluation by Institute of Medicine is sold by several retailers and bookshops. However, Read Time works with Amazon to provide an easier way to purchase books.
To buy Perspectives on Biomarker and Surrogate Endpoint Evaluation by Institute of Medicine on Amazon click the button below.
Buy Perspectives on Biomarker and Surrogate Endpoint Evaluation on Amazon